투석적절도의 효율성open accessThe efficacy of dialysis adequacy
- Authors
- Kim, Su-Hyun; Kim, Yong Kyun; Yang, Chul Woo
- Issue Date
- Jul-2013
- Publisher
- KOREAN MEDICAL ASSOC
- Keywords
- Dialysis; Renal insufficiency; Survival; Uremia; 투석; 말기신부전; 생존율; 요독증
- Citation
- JOURNAL OF THE KOREAN MEDICAL ASSOCIATION, v.56, no.7, pp 583 - 591
- Pages
- 9
- Journal Title
- JOURNAL OF THE KOREAN MEDICAL ASSOCIATION
- Volume
- 56
- Number
- 7
- Start Page
- 583
- End Page
- 591
- URI
- https://scholarworks.bwise.kr/cau/handle/2019.sw.cau/14519
- DOI
- 10.5124/jkma.2013.56.7.583
- ISSN
- 1975-8456
2093-5951
- Abstract
- Adequate dialysis is essential for improving dialysis therapies and reducing all-cause mortality in end-stage renal disease (ESRD) patients. Efficient removal of the uremic toxins in the blood remains the fundamental role of dialysis therapies. Therefore, urea clearance as assessed by urea kinetic modeling (Kt/V-urea) is a surrogate marker for dialysis adequacy in ESRD patients undergoing dialysis, and the NKF-DOQI recommends a Kt/V-urea of no less than 1.2. The current status of dialysis adequacy in Korea has not been fully investigated. Our Clinical Research Center for End Stage Renal Disease revealed that the mean Kt/V-urea in maintenance hemodialysis patients was 1.49 +/- 0.28, and 91.5% of patients satisfied the target level of Kt/V-urea. In addition to Kt/V-urea, clinical parameters such as the volume status, residual renal function, blood pressure, acid-base disorders, anemia, nutrition, inflammation, mineral metabolism, and middle molecule clearance are important for determining adequate dialysis treatment. Further evaluation of clinical parameters is needed to improve dialysis adequacy.
- Files in This Item
- There are no files associated with this item.
- Appears in
Collections - College of Medicine > College of Medicine > 1. Journal Articles
![qrcode](https://api.qrserver.com/v1/create-qr-code/?size=55x55&data=https://scholarworks.bwise.kr/cau/handle/2019.sw.cau/14519)
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.